Gain Therapeutics, Inc. - COM (GANX)

Historical Holders from Q1 2021 to Q1 2025

Symbol
GANX on Nasdaq
CUSIP
36269B105
Type / Class
Equity / COM
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
1.83M
Holdings value
$3.94M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
24
Number of buys
18
Number of sells
-5
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Gain Therapeutics, Inc. - COM (GANX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 59.5K $114K +$9.58K $1.92 1
2024 Q4 1.83M $3.94M +$1.07M $2.16 24
2024 Q3 1.34M $2.4M -$2.12M $1.78 19
2024 Q2 3.04M $3.89M +$108K $1.28 27
2024 Q1 1.87M $7.04M +$1.14M $3.77 26
2023 Q4 1.34M $4.39M +$110K $3.27 23
2023 Q3 1.52M $4.95M +$797K $3.28 24
2023 Q2 1.27M $5.68M +$521K $4.48 24
2023 Q1 1.15M $5.54M +$289K $4.82 22
2022 Q4 1.21M $3.78M -$19.3K $3.13 21
2022 Q3 1.21M $3.95M +$449K $3.26 20
2022 Q2 1.07M $3.87M -$336K $3.60 15
2022 Q1 1.16M $4.75M +$362K $4.09 16
2021 Q4 1.05M $5.7M +$811K $5.38 17
2021 Q3 893K $6.65M -$472K $7.45 13
2021 Q2 894K $8.95M -$1.89M $10.00 12
2021 Q1 1.01M $15M +$15M $14.92 12